{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:48:22Z","timestamp":1793828902589,"version":"4.6.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007875","name":"Tulane University","doi-asserted-by":"publisher","award":["Startup Funds"],"award-info":[{"award-number":["Startup Funds"]}],"id":[{"id":"10.13039\/100007875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007875","name":"Tulane University","doi-asserted-by":"publisher","award":["Provost's Proof of Concept Fund"],"award-info":[{"award-number":["Provost's Proof of Concept Fund"]}],"id":[{"id":"10.13039\/100007875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007875","name":"Tulane University","doi-asserted-by":"publisher","award":["Provost's Proof of Concept Fund"],"award-info":[{"award-number":["Provost's Proof of Concept Fund"]}],"id":[{"id":"10.13039\/100007875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R21AI154284-02"],"award-info":[{"award-number":["5R21AI154284-02"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-55206-w","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T19:21:00Z","timestamp":1735845660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Mutational signature analysis predicts bacterial hypermutation and multidrug resistance"],"prefix":"10.1038","volume":"16","author":[{"given":"Kalen M.","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard G.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7804-1000","authenticated-orcid":false,"given":"Erin A.","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5016-8694","authenticated-orcid":false,"given":"Robert K.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Bojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Wimley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4799-4941","authenticated-orcid":false,"given":"Lisa A.","family":"Morici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-7192","authenticated-orcid":false,"given":"Zachary F.","family":"Pursell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"55206_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1098\/rstb.1995.0015","volume":"347","author":"M Radman","year":"1995","unstructured":"Radman, M., Matic, I., Halliday, J. A. & Taddei, F. Editing DNA replication and recombination by mismatch repair: from bacterial genetics to mechanisms of predisposition to cancer in humans. Philos. Trans. R. Soc. Lond. B Biol. Sci. 347, 97\u2013103 (1995).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"55206_CR2","doi-asserted-by":"publisher","first-page":"8739","DOI":"10.1073\/pnas.95.15.8739","volume":"95","author":"A Baross-Francis","year":"1998","unstructured":"Baross-Francis, A., Andrew, S. E., Penney, J. E. & Jirik, F. R. Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability. Proc. Natl. Acad. Sci. 95, 8739\u20138743 (1998).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"55206_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/366722a0","volume":"366","author":"M Radman","year":"1993","unstructured":"Radman, M. & Wagner, R. Missing mismatch repair. Nature 366, 722 (1993).","journal-title":"Nature"},{"key":"55206_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.mad.2008.02.012","volume":"129","author":"P Hsieh","year":"2008","unstructured":"Hsieh, P. & Yamane, K. DNA mismatch repair: molecular mechanism, cancer, and ageing. Mech. Ageing Dev. 129, 391\u2013407 (2008).","journal-title":"Mech. Ageing Dev."},{"key":"55206_CR5","doi-asserted-by":"crossref","unstructured":"Lee, H., Popodi, E., Tang, H. & Foster, P. L. Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing. Proc. Natl. Acad. Sci. USA 109, E2774\u201383 (2012).","DOI":"10.1073\/pnas.1210309109"},{"key":"55206_CR6","doi-asserted-by":"crossref","unstructured":"Marvig, R. L., Johansen, H. K., Molin, S. & Jelsbak, L. Genome analysis of a transmissible lineage of pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet. 9, e1003741 (2013).","DOI":"10.1371\/journal.pgen.1003741"},{"key":"55206_CR7","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1093\/nar\/gkv271","volume":"43","author":"SA Lujan","year":"2015","unstructured":"Lujan, S. A., Clark, A. B. & Kunkel, T. A. Differences in genome-wide repeat sequence instability conferred by proofreading and mismatch repair defects. Nucleic Acids Res. 43, 4067\u20134074 (2015).","journal-title":"Nucleic Acids Res."},{"key":"55206_CR8","doi-asserted-by":"crossref","unstructured":"Kunkel, T. A. & Erie, D. A. DNA mismatch repair. Annu. Rev. Biochem. 74, 681\u2013710 (2005).","DOI":"10.1146\/annurev.biochem.74.082803.133243"},{"key":"55206_CR9","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979\u2013993 (2012).","journal-title":"Cell"},{"key":"55206_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"55206_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42916-w","volume":"14","author":"C Ruis","year":"2023","unstructured":"Ruis, C. et al. Mutational spectra are associated with bacterial niche. Nat. Commun. 14, 7091 (2023).","journal-title":"Nat. Commun."},{"key":"55206_CR12","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1128\/AAC.49.8.3382-3386.2005","volume":"49","author":"MD Mac\u00eda","year":"2005","unstructured":"Mac\u00eda, M. D. et al. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob. Agents Chemother. 49, 3382\u20133386 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR13","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1099\/mic.0.26751-0","volume":"150","author":"AM Smania","year":"2004","unstructured":"Smania, A. M. et al. Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa. Microbiology 150, 1327\u20131338 (2004).","journal-title":"Microbiology"},{"key":"55206_CR14","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1046\/j.1365-2958.2002.02855.x","volume":"43","author":"A Oliver","year":"2002","unstructured":"Oliver, A., Baquero, F. & Blazquez, J. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol. Microbiol. 43, 1641\u20131650 (2002).","journal-title":"Mol. Microbiol."},{"key":"55206_CR15","doi-asserted-by":"crossref","unstructured":"Varga, J. J. et al. Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains. BMC Genomics 16, 883 (2015).","DOI":"10.1186\/s12864-015-2069-0"},{"key":"55206_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ijmm.2005.12.018","volume":"296","author":"M Hogardt","year":"2006","unstructured":"Hogardt, M., Schubert, S., Adler, K., G\u00f6tzfried, M. & Heesemann, J. Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolates. Int. J. Med. Microbiol. 296, 313\u2013320 (2006).","journal-title":"Int. J. Med. Microbiol."},{"key":"55206_CR17","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1126\/science.288.5469.1251","volume":"288","author":"A Oliver","year":"2000","unstructured":"Oliver, A., Canto\u0301n, R., Campo, P., Baquero, F. & Bla\u0301zquez, J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251\u20131253 (2000).","journal-title":"Science"},{"key":"55206_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0012669","volume":"5","author":"S Feliziani","year":"2010","unstructured":"Feliziani, S. et al. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in pseudomonas aeruginosa from cystic fibrosis chronic airways infections. PLoS One 5, 1\u201312 (2010).","journal-title":"PLoS One"},{"key":"55206_CR19","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1128\/AAC.48.9.3573-3575.2004","volume":"48","author":"O Guti\u00e9rrez","year":"2004","unstructured":"Guti\u00e9rrez, O., Juan, C., P\u00e9rez, J. L. & Oliver, A. Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients. Antimicrob. Agents Chemother. 48, 3573\u20133575 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR20","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1099\/mic.0.29079-0","volume":"152","author":"LMC Hall","year":"2006","unstructured":"Hall, L. M. C. & Henderson-Begg, S. K. Hypermutable bacteria isolated from humans\u2013a critical analysis. Microbiology 152, 2505\u20132514 (2006).","journal-title":"Microbiology"},{"key":"55206_CR21","doi-asserted-by":"publisher","first-page":"e01822","DOI":"10.1128\/mBio.01822-19","volume":"10","author":"PP Khil","year":"2019","unstructured":"Khil, P. P. et al. Dynamic emergence of mismatch repair deficiency facilitates rapid evolution of ceftazidime-avibactam resistance in pseudomonas aeruginosa acute infection. mBio 10, e01822\u201319 (2019).","journal-title":"mBio"},{"key":"55206_CR22","doi-asserted-by":"publisher","first-page":"e0048423","DOI":"10.1128\/msystems.00484-23","volume":"9","author":"SH Nozick","year":"2024","unstructured":"Nozick, S. H. et al. Phenotypes of a Pseudomonas aeruginosa hypermutator lineage that emerged during prolonged mechanical ventilation in a patient without cystic fibrosis. mSystems 9, e0048423 (2024).","journal-title":"mSystems"},{"key":"55206_CR23","doi-asserted-by":"publisher","first-page":"e00043","DOI":"10.1128\/AAC.00043-17","volume":"61","author":"B D\u00f6\u00dfelmann","year":"2017","unstructured":"D\u00f6\u00dfelmann, B. et al. Rapid and consistent evolution of colistin resistance in extensively drug-resistant pseudomonas aeruginosa during morbidostat culture. Antimicrob. Agents Chemother. 61, e00043\u201317 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR24","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1128\/AAC.02462-13","volume":"58","author":"G Cabot","year":"2014","unstructured":"Cabot, G. et al. Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC. Antimicrob. Agents Chemother. 58, 3091\u20133099 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR25","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1128\/AAC.02676-15","volume":"60","author":"G Cabot","year":"2016","unstructured":"Cabot, G. et al. Evolution of pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates. Antimicrob. Agents Chemother. 60, 1767\u20131778 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR26","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1093\/jac\/dkaa206","volume":"75","author":"MA Gomis-Font","year":"2020","unstructured":"Gomis-Font, M. A. et al. In vitro dynamics and mechanisms of resistance development to imipenem and imipenem\/relebactam in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 75, 2508\u20132515 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"55206_CR27","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1093\/jac\/dkab213","volume":"76","author":"I Barcel\u00f3","year":"2021","unstructured":"Barcel\u00f3, I. et al. In vitro evolution of cefepime\/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy. J. Antimicrob. Chemother. 76, 2546\u20132557 (2021).","journal-title":"J. Antimicrob. Chemother."},{"key":"55206_CR28","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1093\/jac\/dkad172","volume":"78","author":"MA Gomis-Font","year":"2023","unstructured":"Gomis-Font, M. A., Sastre-Femenia, M. \u00c0., Taltavull, B., Cabot, G. & Oliver, A. In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa. J. Antimicrob. Chemother. 78, 1785\u20131794 (2023).","journal-title":"J. Antimicrob. Chemother."},{"key":"55206_CR29","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1128\/JB.01479-12","volume":"194","author":"K Held","year":"2012","unstructured":"Held, K., Ramage, E., Jacobs, M., Gallagher, L. & Manoil, C. Sequence-verified two-allele transposon mutant library for pseudomonas aeruginosa PAO1. J. Bacteriol. 194, 6387\u20136389 (2012).","journal-title":"J. Bacteriol."},{"key":"55206_CR30","doi-asserted-by":"publisher","first-page":"14339","DOI":"10.1073\/pnas.2036282100","volume":"100","author":"MA Jacobs","year":"2003","unstructured":"Jacobs, M. A. et al. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. 100, 14339\u201314344 (2003).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"55206_CR31","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1093\/jac\/dks296","volume":"67","author":"Q Yu","year":"2012","unstructured":"Yu, Q. et al. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells. J. Antimicrob. Chemother. 67, 2673\u20132681 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"55206_CR32","doi-asserted-by":"publisher","first-page":"117954841984282","DOI":"10.1177\/1179548419842822","volume":"13","author":"EC Elson","year":"2019","unstructured":"Elson, E. C., Mermis, J., Polineni, D. & Oermann, C. M. Aztreonam lysine inhalation solution in cystic fibrosis. Clin. Med. Insights Circ. Respir. Pulm. Med. 13, 117954841984282 (2019).","journal-title":"Clin. Med. Insights Circ. Respir. Pulm. Med."},{"key":"55206_CR33","doi-asserted-by":"publisher","first-page":"212527","DOI":"10.7573\/dic.212527","volume":"7","author":"M Bassetti","year":"2018","unstructured":"Bassetti, M., Vena, A., Croxatto, A., Righi, E. & Guery, B. How to manage Pseudomonas aeruginosa infections. Drugs Context 7, 212527 (2018).","journal-title":"Drugs Context"},{"key":"55206_CR34","doi-asserted-by":"publisher","first-page":"8437","DOI":"10.1073\/pnas.1918427117","volume":"117","author":"CG Starr","year":"2020","unstructured":"Starr, C. G. et al. Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria. Proc. Natl Acad. Sci. 117, 8437\u20138448 (2020).","journal-title":"Proc. Natl Acad. Sci."},{"key":"55206_CR35","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","volume":"187","author":"PJ Mogayzel","year":"2013","unstructured":"Mogayzel, P. J. et al. Cystic fibrosis pulmonary guidelines. Am. J. Respir. Crit. Care Med. 187, 680\u2013689 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"55206_CR36","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1513\/AnnalsATS.201404-166OC","volume":"11","author":"PJ Mogayzel","year":"2014","unstructured":"Mogayzel, P. J. et al. Cystic fibrosis foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Ann. Am. Thorac. Soc. 11, 1640\u20131650 (2014).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"55206_CR37","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1021\/acsinfecdis.2c00640","volume":"9","author":"J Ghimire","year":"2023","unstructured":"Ghimire, J. et al. Optimization of host cell-compatible, antimicrobial peptides effective against biofilms and clinical isolates of drug-resistant bacteria. ACS Infect. Dis. 9, 952\u2013965 (2023).","journal-title":"ACS Infect. Dis."},{"key":"55206_CR38","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00232-022-00232-2","volume":"255","author":"J Ghimire","year":"2022","unstructured":"Ghimire, J., Guha, S., Nelson, B. J., Morici, L. A. & Wimley, W. C. The remarkable innate resistance of Burkholderia bacteria to cationic antimicrobial peptides: insights into the mechanism of AMP resistance. J. Membr. Biol. 255, 503\u2013511 (2022).","journal-title":"J. Membr. Biol."},{"key":"55206_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mrfmmm.2017.03.005","volume":"797\u2013799","author":"J Sidorenko","year":"2017","unstructured":"Sidorenko, J., Jatsenko, T. & Kivisaar, M. Ongoing evolution of Pseudomonas aeruginosa PAO1 sublines complicates studies of DNA damage repair and tolerance. Mutat. Res. 797\u2013799, 26\u201337 (2017).","journal-title":"Mutat. Res."},{"key":"55206_CR40","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1128\/JB.01050-13","volume":"196","author":"PM Luong","year":"2014","unstructured":"Luong, P. M. et al. Emergence of the P2 phenotype in pseudomonas aeruginosa PAO1 strains involves various mutations in mexT or mexF. J. Bacteriol. 196, 504\u2013513 (2014).","journal-title":"J. Bacteriol."},{"key":"55206_CR41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/CMR.00043-12","volume":"25","author":"L Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez, L. & Hancock, R. E. W. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin. Microbiol Rev. 25, 661\u2013681 (2012).","journal-title":"Clin. Microbiol Rev."},{"key":"55206_CR42","doi-asserted-by":"publisher","first-page":"e3001878","DOI":"10.1371\/journal.pbio.3001878","volume":"20","author":"A Dulanto Chiang","year":"2022","unstructured":"Dulanto Chiang, A. et al. Hypermutator strains of Pseudomonas aeruginosa reveal novel pathways of resistance to combinations of cephalosporin antibiotics and beta-lactamase inhibitors. PLoS Biol. 20, e3001878 (2022).","journal-title":"PLoS Biol."},{"key":"55206_CR43","doi-asserted-by":"publisher","first-page":"538.e7","DOI":"10.1016\/j.cmi.2022.11.014","volume":"29","author":"C L\u00f3pez-Causap\u00e9","year":"2023","unstructured":"L\u00f3pez-Causap\u00e9, C. et al. Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients. Clin. Microbiol. Infect. 29, 538.e7\u2013538.e13 (2023).","journal-title":"Clin. Microbiol. Infect."},{"key":"55206_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05621-5","volume":"7","author":"C L\u00f3pez-Causap\u00e9","year":"2017","unstructured":"L\u00f3pez-Causap\u00e9, C. et al. Evolution of the Pseudomonas aeruginosa mutational resistome in an international cystic fibrosis clone. Sci. Rep. 7, 5555 (2017).","journal-title":"Sci. Rep."},{"key":"55206_CR45","doi-asserted-by":"crossref","unstructured":"Romano, K. P. et al. Mutations in pmrB confer cross-resistance between the LptD inhibitor POL7080 and colistin in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 63, e00511-19 (2019).","DOI":"10.1128\/AAC.00511-19"},{"key":"55206_CR46","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-2958.2006.05522.x","volume":"63","author":"AJ McBroom","year":"2007","unstructured":"McBroom, A. J. & Kuehn, M. J. Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol. Microbiol. 63, 545\u2013558 (2007).","journal-title":"Mol. Microbiol."},{"key":"55206_CR47","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1128\/JB.02004-07","volume":"190","author":"Y Tashiro","year":"2008","unstructured":"Tashiro, Y. et al. Opr86 is essential for viability and is a potential candidate for a protective antigen against biofilm formation by Pseudomonas aeruginosa. J. Bacteriol. 190, 3969\u20133978 (2008).","journal-title":"J. Bacteriol."},{"key":"55206_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13002","volume":"7","author":"N Jochumsen","year":"2016","unstructured":"Jochumsen, N. et al. The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions. Nat. Commun. 7, 13002 (2016).","journal-title":"Nat. Commun."},{"key":"55206_CR49","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1128\/JB.186.2.575-579.2004","volume":"186","author":"SM Moskowitz","year":"2004","unstructured":"Moskowitz, S. M., Ernst, R. K. & Miller, S. I. PmrAB, a two-component regulatory system of pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. 186, 575\u2013579 (2004).","journal-title":"J. Bacteriol."},{"key":"55206_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4236\/aim.2012.21005","volume":"02","author":"D Owusu-Anim","year":"2012","unstructured":"Owusu-Anim, D. & Kwon, D. H. Differential role of two-component regulatory systems (phoPQ and pmrAB) in polymyxin B susceptibility of pseudomonas aeruginosa. Adv. Microbiol 02, 31\u201336 (2012).","journal-title":"Adv. Microbiol"},{"key":"55206_CR51","doi-asserted-by":"publisher","first-page":"e00920","DOI":"10.1128\/IAI.00920-19","volume":"88","author":"NP Giordano","year":"2020","unstructured":"Giordano, N. P., Cian, M. B. & Dalebroux, Z. D. Outer membrane lipid secretion and the innate immune response to gram-negative bacteria. Infect. Immun. 88, e00920 (2020).","journal-title":"Infect. Immun."},{"key":"55206_CR52","doi-asserted-by":"publisher","first-page":"e2018329118","DOI":"10.1073\/pnas.2018329118","volume":"118","author":"MV Douglass","year":"2021","unstructured":"Douglass, M. V., Cl\u00e9on, F. & Trent, M. S. Cardiolipin aids in lipopolysaccharide transport to the gram-negative outer membrane. Proc. Natl. Acad. Sci. 118, e2018329118 (2021).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"55206_CR53","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/pharmaceutics11090470","volume":"11","author":"VE Rees","year":"2019","unstructured":"Rees, V. E., Bulitta, J. B., Oliver, A., Nation, R. L. & Landersdorfer, C. B. Evaluation of tobramycin and ciprofloxacin as a synergistic combination against hypermutable pseudomonas aeruginosa strains via mechanism-based modelling. Pharmaceutics 11, 470 (2019).","journal-title":"Pharmaceutics"},{"key":"55206_CR54","doi-asserted-by":"crossref","unstructured":"Rees, V. E. et al. Meropenem combined with ciprofloxacin combats hypermutable pseudomonas aeruginosa from respiratory infections of cystic fibrosis patients. Antimicrob. Agents Chemother. 62, e01150-18 (2018).","DOI":"10.1128\/AAC.01150-18"},{"key":"55206_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jgar.2021.04.021","volume":"26","author":"JR Tait","year":"2021","unstructured":"Tait, J. R. et al. Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model. J. Glob. Antimicrob. Resist. 26, 55\u201363 (2021).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"55206_CR56","doi-asserted-by":"publisher","first-page":"e0220321","DOI":"10.1128\/aac.02203-21","volume":"66","author":"H Bilal","year":"2022","unstructured":"Bilal, H. et al. Simulated intravenous versus inhaled tobramycin with or without intravenous ceftazidime evaluated against hypermutable pseudomonas aeruginosa via a dynamic biofilm model and mechanism-based modeling. Antimicrob. Agents Chemother. 66, e0220321 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR57","doi-asserted-by":"publisher","first-page":"e01293","DOI":"10.1128\/AAC.01293-19","volume":"63","author":"H Bilal","year":"2019","unstructured":"Bilal, H. et al. Synergistic meropenem-tobramycin combination dosage regimens against clinical hypermutable pseudomonas aeruginosa at simulated epithelial lining fluid concentrations in a dynamic biofilm model. Antimicrob. Agents Chemother. 63, e01293\u201319 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR58","doi-asserted-by":"publisher","first-page":"e01044","DOI":"10.1128\/AAC.01044-19","volume":"63","author":"A Bolard","year":"2019","unstructured":"Bolard, A. et al. Production of norspermidine contributes to aminoglycoside resistance in pmrAB mutants of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 63, e01044\u201319 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR59","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1513\/AnnalsATS.201310-352OC","volume":"11","author":"JA Nick","year":"2014","unstructured":"Nick, J. A. et al. Azithromycin may antagonize inhaled tobramycin when targeting Pseudomonas aeruginosa in cystic fibrosis. Ann. Am. Thorac. Soc. 11, 342\u2013350 (2014).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"55206_CR60","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1128\/AAC.00196-16","volume":"60","author":"E Rojo-Molinero","year":"2016","unstructured":"Rojo-Molinero, E. et al. Sequential treatment of biofilms with aztreonam and tobramycin is a novel strategy for combating pseudomonas aeruginosa chronic respiratory infections. Antimicrob. Agents Chemother. 60, 2912\u20132922 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR61","doi-asserted-by":"publisher","first-page":"943346","DOI":"10.3389\/fcimb.2022.943346","volume":"12","author":"KM Hall","year":"2022","unstructured":"Hall, K. M., Pursell, Z. F. & Morici, L. A. The role of the Pseudomonas aeruginosa hypermutator phenotype on the shift from acute to chronic virulence during respiratory infection. Front. Cell Infect. Microbiol. 12, 943346 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"55206_CR62","doi-asserted-by":"crossref","unstructured":"Colque, C. A. et al. Hypermutator pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patients. Antimicrob. Agents Chemother. 64,e02142-19 (2020).","DOI":"10.1128\/AAC.02142-19"},{"key":"55206_CR63","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1073\/pnas.77.2.1063","volume":"77","author":"BW Glickman","year":"1980","unstructured":"Glickman, B. W. & Radman, M. Escherichia coli mutator mutants deficient in methylation-instructed DNA mismatch correction. Proc. Natl. Acad. Sci. 77, 1063\u20131067 (1980).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"55206_CR64","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/genetics\/115.4.605","volume":"115","author":"M Jones","year":"1987","unstructured":"Jones, M., Wagner, R. & Radman, M. Repair of a mismatch is influenced by the base composition of the surrounding nucleotide sequence. Genetics 115, 605\u2013610 (1987).","journal-title":"Genetics"},{"key":"55206_CR65","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1101\/gr.226845.117","volume":"28","author":"B Meier","year":"2018","unstructured":"Meier, B. et al. Mutational signatures of DNA mismatch repair deficiency in C. elegans and human cancers. Genome Res. 28, 666\u2013675 (2018).","journal-title":"Genome Res."},{"key":"55206_CR66","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11033-021-06749-4","volume":"49","author":"ST Parvathy","year":"2022","unstructured":"Parvathy, S. T., Udayasuriyan, V. & Bhadana, V. Codon usage bias. Mol. Biol. Rep. 49, 539\u2013565 (2022).","journal-title":"Mol. Biol. Rep."},{"key":"55206_CR67","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0378-1119(02)00503-6","volume":"289","author":"RJ Grocock","year":"2002","unstructured":"Grocock, R. J. & Sharp, P. M. Synonymous codon usage in pseudomonas Aeruginosa PA01. Gene 289, 131\u2013139 (2002).","journal-title":"Gene"},{"key":"55206_CR68","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.1093\/nar\/16.19.9323","volume":"16","author":"SEH West","year":"1988","unstructured":"West, S. E. H. & Iglewski, B. H. Codon usage in Pseudomonas aeruginosa. Nucleic Acids Res 16, 9323\u20139335 (1988).","journal-title":"Nucleic Acids Res"},{"key":"55206_CR69","doi-asserted-by":"publisher","first-page":"e0190095","DOI":"10.1371\/journal.pone.0190095","volume":"12","author":"R Goto","year":"2017","unstructured":"Goto, R., Miki, T., Nakamura, N., Fujimoto, M. & Okada, N. Salmonella typhimurium PagP- and UgtL-dependent resistance to antimicrobial peptides contributes to the gut colonization. PLoS One 12, e0190095 (2017).","journal-title":"PLoS One"},{"key":"55206_CR70","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1513\/AnnalsATS.201801-012OC","volume":"15","author":"JD Cogen","year":"2018","unstructured":"Cogen, J. D. et al. Chronic azithromycin use in cystic fibrosis and risk of treatment-emergent respiratory pathogens. Ann. Am. Thorac. Soc. 15, 702\u2013709 (2018).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"55206_CR71","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10096-015-2347-4","volume":"34","author":"N Principi","year":"2015","unstructured":"Principi, N., Blasi, F. & Esposito, S. Azithromycin use in patients with cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 34, 1071\u20131079 (2015).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"55206_CR72","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","volume":"16","author":"G D\u00f6ring","year":"2000","unstructured":"D\u00f6ring, G. et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur. Respiratory J. 16, 749 (2000).","journal-title":"Eur. Respiratory J."},{"key":"55206_CR73","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1128\/AAC.03954-14","volume":"59","author":"VN Kos","year":"2015","unstructured":"Kos, V. N. et al. The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob. Agents Chemother. 59, 427\u2013436 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR74","doi-asserted-by":"publisher","first-page":"e1004651","DOI":"10.1371\/journal.pgen.1004651","volume":"10","author":"S Feliziani","year":"2014","unstructured":"Feliziani, S. et al. Coexistence and within-host evolution of diversified lineages of hypermutable pseudomonas aeruginosa in long-term cystic fibrosis infections. PLoS Genet 10, e1004651 (2014).","journal-title":"PLoS Genet"},{"key":"55206_CR75","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1128\/JB.00120-07","volume":"189","author":"A Mena","year":"2007","unstructured":"Mena, A. et al. Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice. J. Bacteriol. 189, 3665\u20133668 (2007).","journal-title":"J. Bacteriol."},{"key":"55206_CR76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1574-6968.2002.tb11452.x","volume":"217","author":"A Oliver","year":"2002","unstructured":"Oliver, A., S\u00e1nchez, J. M. & Blazquez, J. Characterization of the GO system of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 217, 31\u201335 (2002).","journal-title":"FEMS Microbiol. Lett."},{"key":"55206_CR77","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1574-6968.2011.02383.x","volume":"324","author":"LF Mandsberg","year":"2011","unstructured":"Mandsberg, L. F. et al. Development of antibiotic resistance and up-regulation of the antimutator gene pfpI in mutator Pseudomonas aeruginosa due to inactivation of two DNA oxidative repair genes (mutY, mutM). FEMS Microbiol. Lett. 324, 28\u201337 (2011).","journal-title":"FEMS Microbiol. Lett."},{"key":"55206_CR78","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1128\/JB.00732-09","volume":"191","author":"JF Petrosino","year":"2009","unstructured":"Petrosino, J. F., Galhardo, R. S., Morales, L. D. & Rosenberg, S. M. Stress-induced \u03b2-lactam antibiotic resistance mutation and sequences of stationary-phase mutations in the Escherichia coli chromosome. J. Bacteriol. 191, 5881\u20135889 (2009).","journal-title":"J. Bacteriol."},{"key":"55206_CR79","doi-asserted-by":"crossref","unstructured":"Gutierrez, A. et al. \u03b2-lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication fidelity. Nat. Commun. 4, 1610 (2013).","DOI":"10.1038\/ncomms2607"},{"key":"55206_CR80","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1126\/science.1101630","volume":"305","author":"C Miller","year":"2004","unstructured":"Miller, C. et al. SOS response induction by \u03b2-lactams and bacterial defense against antibiotic lethality. Science 305, 1629\u20131631 (2004).","journal-title":"Science"},{"key":"55206_CR81","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1128\/AAC.01415-16","volume":"60","author":"LY Song","year":"2016","unstructured":"Song, L. Y. et al. Mutational consequences of ciprofloxacin in Escherichia coli. Antimicrob. Agents Chemother. 60, 6165\u20136172 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR82","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1128\/JB.187.4.1515-1518.2005","volume":"187","author":"T P\u00e9rez-Capilla","year":"2005","unstructured":"P\u00e9rez-Capilla, T. et al. SOS-independent induction of dinB transcription by \u03b2-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. J. Bacteriol. 187, 1515\u20131518 (2005).","journal-title":"J. Bacteriol."},{"key":"55206_CR83","doi-asserted-by":"publisher","first-page":"e18824","DOI":"10.1371\/journal.pone.0018824","volume":"6","author":"LH Sanders","year":"2011","unstructured":"Sanders, L. H. et al. Epistatic roles for pseudomonas aeruginosa MutS and DinB (DNA Pol IV) in coping with reactive oxygen species-induced DNA damage. PLOS One 6, e18824 (2011).","journal-title":"PLOS One"},{"key":"55206_CR84","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1073\/pnas.97.2.565","volume":"97","author":"A Maor-Shoshani","year":"2000","unstructured":"Maor-Shoshani, A., Reuven, N. B., Tomer, G. & Livneh, Z. Highly mutagenic replication by DNA polymerase V (UmuC) provides a mechanistic basis for SOS untargeted mutagenesis. Proc. Natl. Acad. Sci. 97, 565\u2013570 (2000).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"55206_CR85","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s004380100541","volume":"266","author":"SR Kim","year":"2001","unstructured":"Kim, S. R., Matsui, K., Yamada, M., Gruz, P. & Nohmi, T. Roles of chromosomal and episomal dinB genes encoding DNA pol IV in targeted and untargeted mutagenesis in Escherichia coli. Mol. Genet. Genomics 266, 207\u2013215 (2001).","journal-title":"Mol. Genet. Genomics"},{"key":"55206_CR86","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1128\/JB.187.19.6862-6866.2005","volume":"187","author":"W Kuban","year":"2005","unstructured":"Kuban, W. et al. Mutator phenotype resulting from DNA polymerase IV overproduction in Escherichia coli: preferential mutagenesis on the lagging strand. J. Bacteriol. 187, 6862\u20136866 (2005).","journal-title":"J. Bacteriol."},{"key":"55206_CR87","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S1097-2765(01)00204-0","volume":"7","author":"GJ McKenzie","year":"2001","unstructured":"McKenzie, G. J., Lee, P. L., Lombardo, M.-J., Hastings, P. J. & Rosenberg, S. M. SOS mutator DNA polymerase IV functions in adaptive mutation and not adaptive amplification. Mol. Cell 7, 571\u2013579 (2001).","journal-title":"Mol. Cell"},{"key":"55206_CR88","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1128\/AAC.00464-08","volume":"52","author":"K Tanimoto","year":"2008","unstructured":"Tanimoto, K., Tomita, H., Fujimoto, S., Okuzumi, K. & Ike, Y. Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation. Antimicrob. Agents Chemother. 52, 3795\u20133800 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR89","doi-asserted-by":"publisher","first-page":"e00744","DOI":"10.1128\/AAC.00744-19","volume":"63","author":"HH Mehta","year":"2019","unstructured":"Mehta, H. H. et al. The essential role of hypermutation in rapid adaptation to antibiotic stress. Antimicrob. Agents Chemother. 63, e00744\u201319 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55206_CR90","doi-asserted-by":"publisher","first-page":"e0140489","DOI":"10.1371\/journal.pone.0140489","volume":"10","author":"TG Hammerstrom","year":"2015","unstructured":"Hammerstrom, T. G., Beabout, K., Clements, T. P., Saxer, G. & Shamoo, Y. Acinetobacter baumannii repeatedly evolves a hypermutator phenotype in response to tigecycline that effectively surveys evolutionary trajectories to resistance. PLoS One 10, e0140489 (2015).","journal-title":"PLoS One"},{"key":"55206_CR91","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/clinchem\/hvab173","volume":"68","author":"S Miller","year":"2021","unstructured":"Miller, S. & Chiu, C. The role of metagenomics and next-generation sequencing in infectious disease diagnosis. Clin. Chem. 68, 115\u2013124 (2021).","journal-title":"Clin. Chem."},{"key":"55206_CR92","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1086\/374937","volume":"187","author":"A Prunier","year":"2003","unstructured":"Prunier, A. et al. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J. Infect. Dis. 187, 1709\u20131716 (2003).","journal-title":"J. Infect. Dis."},{"key":"55206_CR93","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1128\/JB.184.2.605-609.2002","volume":"184","author":"E Denamur","year":"2002","unstructured":"Denamur, E. et al. High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J. Bacteriol. 184, 605\u2013609 (2002).","journal-title":"J. Bacteriol."},{"key":"55206_CR94","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1126\/science.277.5333.1833","volume":"277","author":"I Matic","year":"1997","unstructured":"Matic, I. et al. Highly variable mutation rates in commensal and pathogenic Escherichia coli. Science 277, 1833\u20131834 (1997).","journal-title":"Science"},{"key":"55206_CR95","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/jac\/dkv378","volume":"71","author":"P Komp Lindgren","year":"2016","unstructured":"Komp Lindgren, P., Higgins, P. G., Seifert, H. & Cars, O. Prevalence of hypermutators among clinical Acinetobacter baumannii isolates. J. Antimicrob. Chemother. 71, 661\u2013665 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"55206_CR96","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mrfmmm.2017.06.002","volume":"800\u2013802","author":"M Karami-Zarandi","year":"2017","unstructured":"Karami-Zarandi, M. et al. Variable spontaneous mutation rate in clinical strains of multidrug-resistant Acinetobacter baumannii and differentially expressed proteins in a hypermutator strain. Mutat. Res. 800\u2013802, 37\u201345 (2017).","journal-title":"Mutat. Res."},{"key":"55206_CR97","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4939-0554-6_12","volume":"1151","author":"DE Deatherage","year":"2014","unstructured":"Deatherage, D. E. & Barrick, J. E. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol. Biol. 1151, 165\u2013188 (2014).","journal-title":"Methods Mol. Biol."},{"key":"55206_CR98","doi-asserted-by":"crossref","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","DOI":"10.1093\/gigascience\/giab008"},{"key":"55206_CR99","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham, H. et al. Welcome to the Tidyverse. J. Open Source Softw. 4, 1686 (2019).","journal-title":"J. Open Source Softw."},{"key":"55206_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-022-08357-3","volume":"23","author":"F Manders","year":"2022","unstructured":"Manders, F. et al. MutationalPatterns: the one stop shop for the analysis of mutational processes. BMC Genomics 23, 134 (2022).","journal-title":"BMC Genomics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55206-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T20:03:19Z","timestamp":1735848199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55206-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55206"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-55206-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4529716\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.M.H., L.G.W., Z.F.P., and L.A.M. are inventors of patent application #PCT\/US2024\/014280. K.M.H. and L.G.W. are employed by and are shareholders of Informuta, Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}